What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder
JAMA Psychiatry
.
2016 Jul 1;73(7):651-2.
doi: 10.1001/jamapsychiatry.2016.0780.
Author
Gerard Sanacora
1
Affiliation
1
Department of Psychiatry, Yale University, New Haven, Connecticut.
PMID:
27303925
DOI:
10.1001/jamapsychiatry.2016.0780
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antidepressive Agents
Depressive Disorder, Major*
Glutamic Acid*
Humans
Substances
Antidepressive Agents
Glutamic Acid